Cary Street Partners Investment Advisory’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $268K | Buy |
1,040
+20
| +2% | +$5.16K | 0.13% | 176 |
|
|
2025
Q1 | $228K | Sell |
1,020
-165
| -14% | -$36.9K | 0.13% | 189 |
|
|
2024
Q4 | $271K | Sell |
1,185
-36
| -3% | -$8.23K | 0.18% | 132 |
|
|
2024
Q3 | $298K | Buy |
1,221
+17
| +1% | +$4.15K | 0.01% | 626 |
|
|
2024
Q2 | $231K | Sell |
1,204
-3
| -0.2% | -$574 | 0.01% | 670 |
|
|
2024
Q1 | $239K | Sell |
1,207
-70
| -5% | -$13.9K | 0.01% | 614 |
|
|
2023
Q4 | $220K | Buy |
1,277
+1,120
| +713% | +$193K | 0.01% | 596 |
|
|
2023
Q3 | $23.2K | Buy |
157
+127
| +423% | +$18.8K | ﹤0.01% | 1069 |
|
|
2023
Q2 | $6.56K | Buy |
+30
| New | +$6.56K | ﹤0.01% | 1341 |
|